Clozapine

This classification denotes a 5-ht3 receptor antagonist and antipsychotic agent with the molecular formula C18H19ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J60AR2IKIC, chemically known as 8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(b,e)(1,4)diazepine but generally known as clozapine, which bears US NIH Compound Identifier 2818. European Medicines Agency schedules Clozapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06787MIG. The term CLOZAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules clozapine in its Anatomical Therapeutic Chemical (ATC) Classification. CLOZAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clozapine under HS 29335995 and SITC 51576. As of Q4 2014, CLOZAPINE remains the US FDA Preferred Term for this commodity. Clozapine bears US NLM identifiers UMLS ID C0009079 and NCI Concept Code C28936. SMILES: CLC1CC2NC(=C3C(=NC2CC1)CCCC3)N1CCN(CC1)C.